TG Therapeutics Inc. (TGTX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    TG Therapeutics Inc.

    NASDAQ: TGTX · Real-Time Price · USD
    32.38
    0.17 (0.53%)
    At close: Sep 08, 2025, 3:59 PM

    TG Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 187.06 191.33 -7.86 -7.07
    PEG Ratio
    		 2.36 -1.81 0.18 -0.83
    PS Ratio
    		 13.29 10.38 575.19 375.58
    PB Ratio
    		 19.67 15.11 -1.05 -1.89
    P/FCF Ratio
    		 -107.84 -77.18 -9.09 -8.49
    P/OCF Ratio
    		 -107.96 -77.18 -9.09 -8.5
    OCF/S Ratio
    		 -0.12 -0.13 -63.26 -44.2
    Debt / Equity Ratio
    		 1.14 0.69 -0.05 -0.06
    Quick Ratio
    		 5.03 5.18 3.16 5.42
    Current Ratio
    		 6.25 5.92 3.16 5.06
    Asset Turnover
    		 0.57 0.71 0.01 0.02
    Interest Coverage
    		 1.75 1.64 -18.92 -61.15
    Return on Equity
    		 0.11 0.08 0.13 0.27
    Return on Assets
    		 0.04 0.04 -1.05 -0.94
    Return on Invested Capital
    		 0.08 0.07 -1.38 -1.11
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.88 0.94 0.90 0.88
    Net Profit Margin
    		 0.07 0.05 -73.19 -53.15
    Pretax Profit Margin
    		 0.08 0.06 -71.22 -52.04
    Operating Profit Margin
    		 0.13 0.09 -69.24 -51.54
    FCF Margin
    		 -0.12 -0.13 -63.26 -44.26
    EBITDA Margin
    		 0.15 0.11 -67.37 -51.12

    Add to Watchlist